sur ABIVAX (EPA:ABVX)
JP Morgan Chase exceeds 5% threshold in ABIVAX
On September 9, 2025, ABIVAX announced that JP Morgan Chase & Co. had exceeded the 5% threshold of its share capital. This crossing, recorded on September 5, resulted from an increase in the number of shares held through assimilation.
In total, JP Morgan holds 4,042,393 shares, representing 5.35% of the capital and 4.76% of the voting rights. This transaction primarily involves JP Morgan Prime Inc., JP Morgan Securities plc, and JP Morgan Securities LLC.
JP Morgan Securities LLC holds 3,603,156 shares through various contracts. In addition, this subsidiary holds 256,118 depository receipts. JP Morgan Securities plc also holds depository receipts.
The company also holds 77,848 shares through equity swap contracts, thus postponing its presence in ABIVAX's capital in the long term.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIVAX